Deprescribing NSAIDs: The Potential Role of Community Pharmacists
Open Access
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are largely used for controlling various pain conditions and are widely available in community pharmacies, with and without prescription. Despite their effectiveness, NSAIDs can pose significant risks due to potential side effects and drug interactions, particularly in polypharmacy and comorbidity contexts and for vulnerable users. This study investigated whether and how NSAIDs deprescribing can be conducted at the community pharmacy level by assessing pharmacists’ confidence, attitudes, and potential barriers and facilitators. Additionally, we aimed to identify any deprescribing guidelines that pharmacists could use. A literature search and a cross-sectional digital questionnaire targeting community pharmacists in Norway were conducted. Results showed that study participants (N = 73) feel confident in identifying needs for deprescribing NSAIDs but barriers such as time constraints, lack of financial compensation, and communication challenges were noted. Participants reported positive attitudes toward deprescribing but highlighted a need for better guidelines and training. This study highlights a gap in specific guidelines for deprescribing NSAIDs and a potential for enhancing pharmacists’ roles in the deprescribing process, for example, through training and improved financial incentives. Further research is encouraged to develop concrete strategies for an effective implementation where community pharmacists can be involved in the deprescribing of NSAIDs.Keywords
This publication has 75 references indexed in Scilit:
- Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortiumAging Clinical and Experimental Research, 2024
- Implementation of pharmacist-led deprescribing in collaborative primary care settingsInternational Journal of Clinical Pharmacy, 2022
- Response rates of online surveys in published research: A meta-analysisComputers in Human Behavior Reports, 2022
- “I really had somebody in my corner.” Patient experiences with a pharmacist-led opioid tapering programJournal of the American Pharmacists Association, 2022
- Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term OpioidsJAMA, 2021
- MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General PracticeDrugs & Aging, 2021
- Community pharmacists’ perceptions on providing fall prevention services: a mixed-methods studyInternational Journal of Clinical Pharmacy, 2021
- The role of social isolation in physical and emotional outcomes among patients with chronic painGeneral Hospital Psychiatry, 2021
- Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain CareEXPLORE, 2018
- Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effectsEuropean Journal of Clinical Pharmacology, 2014